IP Library Granted Patent US 12,447,348
Granted Patent B2
US 12,447,348 · App. 17/989,599 · Granted Oct 21, 2025

Secondary verification of MRI exposure at an implantable medical device

Inventors: Jonathan D. Edmonson (Blaine, MN); Michael W. Heinks (New Brighton, MN)
Assignee: Medtronic, Inc.
A61N1/3718A61N1/36542A61N1/37217
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,447,348
App. No.
17/989,599
Granted
Oct 21, 2025
Kind
B2
Abstract

Implantable medical devices include a first sensor for detecting a magnetic field that indicates an exposure mode of operation is appropriate. The implantable medical devices include a second sensor for detecting whether an MRI characteristic is present that indicates whether MRI or non-MRI post exposure diagnostics and other actions should be implemented and may also indicate whether the exposure mode should be MRI or non-MRI specific. An MRI post exposure diagnostic may perform pacing capture threshold tests and the post exposure pacing amplitude output may be kept at a higher than normal level. The second sensor may be an overvoltage clamp circuit of a telemetry coil that indicates whether an overvoltage condition on the telemetry coil is occurring to indicate whether an MRI characteristic is present. The second sensor may be a second threshold magnetic sensor, an accelerometer, or a microphone to indicate whether an MRI characteristic is present.

Claims (49)

1. An implantable medical device, comprising:

a first sensor for detecting a first magnetic field;

a second sensor detecting whether an MRI characteristic is detected; and

a controller in communication with the first sensor and the second sensor, the controller selecting a mode of operation between a normal mode and an exposure mode,

wherein upon the first sensor detecting the magnetic field, the controller activates the exposure mode, while the exposure mode is activated, the controller detects whether an MRI characteristic is detected at a second sensor,

when the MRI characteristic is detected at the second sensor during the exposure mode, then upon concluding the exposure mode once the first sensor no longer detects the first magnetic field, the controller performs an MRI post exposure diagnostics procedure, and

when the MRI characteristic is not detected at the second sensor during exposure mode, then upon concluding the exposure mode once the first sensor no longer detects the first magnetic field, the controller performs a non-MRI post exposure diagnostics procedure.

2. The implantable medical device of claim 1 , further comprising a memory in communication with the controller, and wherein when the MRI characteristic is detected at the second sensor during exposure mode, then the controller logs a reason for entering the exposure mode as an MRI event in the memory of the implantable medical device.

3. The implantable medical device of claim 2 , wherein when the MRI characteristic is not detected at the second sensor during exposure mode, then the controller logs a reason for entering the exposure mode as a non-MRI event in the memory of the implantable medical device.

4. The implantable medical device of claim 1 , wherein the first sensor is a Hall effect sensor of the implantable medical device.

5. The implantable medical device of claim 1 , further comprising a telemetry circuit in communication with the controller and coupled to a telemetry coil, and wherein the second sensor is a overvoltage clamp coupled to the telemetry coil and the MRI characteristic is an overvoltage occurring on the telemetry coil that triggers the overvoltage clamp.

6. The implantable medical device of claim 1 , further comprising a pacing output circuit and wherein when the controller selects the exposure mode, the controller causes the pacing output circuit to increase a pacing output amplitude and wherein the controller performs the MRI post exposure diagnostics procedure by maintaining the increased pacing output amplitude of the pacing output circuit.

7. The implantable medical device of claim 6 , wherein the controller performs the non-MRI post exposure diagnostics procedure by returning the pacing output circuit to a pacing output amplitude in use prior to the controller selecting the exposure mode.

8. The implantable medical device of claim 1 , wherein the controller performs the MRI post exposure diagnostics procedure by performing pacing capture threshold tests.

9. The implantable medical device of claim 1 , further comprising a pacing output circuit, and wherein when the MRI characteristic is not detected at the second sensor during exposure mode, then the controller causes the pacing output circuit to maintain a pacing output amplitude in use prior to entering the exposure mode.

10. An implantable medical system, comprising

an implantable medical lead having distal electrodes to output pacing signals; and

an implantable medical device coupled to the implantable medical lead and comprising:

a first sensor for detecting a first magnetic field;

a second sensor detecting whether an MRI characteristic is detected;

a pacing output circuit electrically coupled to the distal electrodes; and

a controller in communication with the first sensor, the second sensor, and the pacing output circuit, where the controller selects a mode of operation between a normal mode and an exposure mode,

wherein upon the first sensor detecting the magnetic field, the controller activates the exposure mode, while the exposure mode is activated, the controller detects whether an MRI characteristic is detected at a second sensor,

when the MRI characteristic is detected at the second sensor during the exposure mode, then upon concluding the exposure mode once the first sensor no longer detects the first magnetic field, the controller performs an MRI post exposure diagnostics procedure, and

when the MRI characteristic is not detected at the second sensor during exposure mode, then upon concluding the exposure mode once the first sensor no longer detects the first magnetic field, the controller performs a non-MRI post exposure diagnostics procedure.

11. The implantable medical system of claim 10 , further comprising:

a memory in communication with the controller;

a telemetry circuit coupled to a telemetry coil and in communication with the controller; and

wherein when the MRI characteristic is detected at the second sensor during exposure mode, then the controller logs a reason for entering the exposure mode as an MRI event in the memory of the implantable medical device,

wherein when the MRI characteristic is not detected at the second sensor during exposure mode, then the controller logs a reason for entering the exposure mode as a non-MRI event in the memory of the implantable medical device.

12. The implantable medical system of claim 10 , wherein the first sensor is a Hall effect sensor of the implantable medical device and wherein the second sensor is an overvoltage clamp coupled to a telemetry coil and the MRI characteristic is an overvoltage occurring on the telemetry coil that triggers the overvoltage clamp.

13. The implantable medical system of claim 10 , wherein when the controller selects the exposure mode, the controller causes the pacing output circuit to increase a pacing output amplitude, wherein the controller performs the MRI post exposure diagnostics procedure by maintaining the increased pacing output amplitude of the pacing output circuit and by performing pacing capture threshold tests, and wherein the controller performs the non-MRI post exposure diagnostics procedure by returning the pacing output circuit to a pacing output amplitude in use prior to the controller selecting the exposure mode.

14. A method of controlling operations of an implantable medical device when exposed to a magnetic field, comprising:

detecting a first magnetic field at a first sensor;

upon detecting the magnetic field, entering an exposure mode of operation at the implantable medical device;

while the implantable medical device is in the exposure mode, detecting whether an MRI characteristic is detected at a second sensor;

when the MRI characteristic is detected at the second sensor during exposure mode, then upon concluding the exposure mode once the first sensor no longer detects the first magnetic field, performing an MRI post exposure diagnostics procedure at the implantable medical device; and

when the MRI characteristic is not detected at the second sensor during exposure mode, then upon concluding the exposure mode once the first sensor no longer detects the first magnetic field, performing a non-MRI post exposure diagnostics procedure at the implantable medical device.

15. The method of claim 1 , wherein when the MRI characteristic is detected at the second sensor during exposure mode, then logging a reason for entering the exposure mode as an MRI event in memory of the implantable medical device.

16. The method of claim 1 , wherein when the MRI characteristic is not detected at the second sensor during exposure mode, then logging a reason for entering the exposure mode as a non-MRI event in memory of the implantable medical device.

17. The method of claim 1 , wherein the first sensor is a Hall effect sensor of the implantable medical device.

18. The method of claim 1 , wherein the second sensor is an overvoltage clamp on a telemetry coil of the implantable medical device and the MRI characteristic is an overvoltage occurring on the telemetry coil that triggers the overvoltage clamp.

19. The method of claim 1 , wherein the first and second sensor are provided by a multi-magnetic threshold sensor where the first sensor has a first threshold and the second sensor has a second threshold that is higher than the first threshold, and wherein the MRI characteristic is a magnetic field intensity that exceeds the second threshold.

20. The method of claim 1 , wherein the second sensor is an accelerometer and the MRI characteristic is an acceleration that exceeds an acceleration threshold.

21. The method of claim 1 , wherein the second sensor is a microphone and the MRI characteristic is an amount of acoustic energy that exceeds an acoustic threshold.

22. The method of claim 1 , wherein entering the exposure mode causes an increase in pacing output amplitude of the implantable medical device and wherein the MRI post exposure diagnostics procedure comprises maintaining the increased pacing output amplitude at the implantable medical device.

23. The method of claim 22 , wherein the non-MRI post exposure diagnostics procedure comprises returning to a pacing output amplitude in use prior to entering the exposure mode.

24. The method of claim 1 , wherein the MRI post exposure diagnostics procedure comprises performing pacing capture threshold tests at the implantable medical device.

25. The method of claim 1 , wherein when the MRI characteristic is not detected at the second sensor during exposure mode, then maintaining a pacing output amplitude in use prior to entering the exposure mode.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2022
From: EDMONSON, JONATHAN D.; HEINKS, MICHAEL W.
To: MEDTRONIC, INC.
Reel/Frame 061818/0501 →
Continuity (2)
Provisional Application 63290043 · Dec 15, 2021
Related Publication 20230181912A1 · Jun 15, 2023
References Cited (97)
US 5174289A · Cohen · 1992 [cited by applicant]
US 5722998A · Prutchi et al. · 1998 [cited by applicant]
US 5978710A · Prutchi et al. · 1999 [cited by applicant]
US 6937906B2 · Terry et al. · 2005 [cited by applicant]
US 7039810B1 · Nichols · 2006 [cited by applicant]
US 7050855B2 · Zeijlemaker et al. · 2006 [cited by applicant]
US 7076283B2 · Cho et al. · 2006 [cited by applicant]
US 7212863B2 · Strandberg · 2007 [cited by applicant]
US 7561915B1 · Cooke et al. · 2009 [cited by applicant]
US 7623930B2 · Zeijiemaker et al. · 2009 [cited by applicant]
US 7697988B2 · Clement et al. · 2010 [cited by applicant]
US 8014867B2 · Cooke et al. · 2011 [cited by applicant]
US 8046063B2 · Betzold · 2011 [cited by applicant]
US 8121678B2 · Linder et al. · 2012 [cited by applicant]
US 8200334B1 · Min et al. · 2012 [cited by applicant]
US 8433408B2 · Ellingson et al. · 2013 [cited by applicant]
US 8437862B2 · Yoon et al. · 2013 [cited by applicant]
US 8467882B2 · Ellingson et al. · 2013 [cited by applicant]
US 8538550B2 · Stubbs et al. · 2013 [cited by applicant]
US 8554318B2 · Legay · 2013 [cited by applicant]
US 8737862B2 · Manico et al. · 2014 [cited by applicant]
US 8744578B2 · Ellingson · 2014 [cited by applicant]
US 8805496B2 · Ellingson · 2014 [cited by applicant]
US 8818506B2 · Legay · 2014 [cited by applicant]
US 8886317B2 · Cooke et al. · 2014 [cited by applicant]
US 8896462B2 · Skoldengen et al. · 2014 [cited by applicant]
US 8929995B2 · Stancer et al. · 2015 [cited by applicant]
US 9008788B2 · Jenison · 2015 [cited by applicant]
US 9095721B2 · Stancer · 2015 [cited by examiner]
US 9138584B2 · Stancer et al. · 2015 [cited by applicant]
US 9174058B2 · Ellingson et al. · 2015 [cited by applicant]
US 9272152B2 · Lalonde et al. · 2016 [cited by applicant]
US 9919158B2 · Ellingson et al. · 2018 [cited by applicant]
US 10130282B2 · Goetz · 2018 [cited by applicant]
US 10130822B2 · Legay et al. · 2018 [cited by applicant]
US 10293167B2 · Yoon et al. · 2019 [cited by applicant]
US 10441798B2 · Yoon et al. · 2019 [cited by applicant]
US 10493286B2 · Ellingson et al. · 2019 [cited by applicant]
US 10668292B2 · Pei et al. · 2020 [cited by applicant]
US 10744320B2 · Newman et al. · 2020 [cited by applicant]
US 10981010B2 · Yoon et al. · 2021 [cited by applicant]
US 11253707B2 · Yoon et al. · 2022 [cited by applicant]
US 11478647B2 · Ellingson et al. · 2022 [cited by applicant]
US 11724111B2 · Yoon et al. · 2023 [cited by applicant]
US 11938326B2 · Yoon et al. · 2024 [cited by applicant]
US 20030144705A1 · Funke · 2003 [cited by applicant]
US 20030144706A1 · Funke · 2003 [cited by applicant]
US 20040024421A1 · Ideker et al. · 2004 [cited by applicant]
US 20040030256A1 · Lin · 2004 [cited by applicant]
US 20040254614A1 · Spinelli et al. · 2004 [cited by applicant]
US 20050096708A1 · Seim et al. · 2005 [cited by applicant]
US 20050149126A1 · Libbus · 2005 [cited by applicant]
US 20060167496A1 · Nelson et al. · 2006 [cited by applicant]
US 20060293591A1 · Wahlstrand et al. · 2006 [cited by applicant]
US 20070179558A1 · Gliner et al. · 2007 [cited by applicant]
US 20070265662A1 · Ufford · 2007 [cited by applicant]
US 20080154342A1 · Digby et al. · 2008 [cited by applicant]
US 20090138058A1 · Cooke et al. · 2009 [cited by applicant]
US 20090157146A1 · Linder et al. · 2009 [cited by applicant]
US 20100087892A1 · Stubbs · 2010 [cited by examiner]
US 20100137945A1 · Gadagkar et al. · 2010 [cited by applicant]
US 20100137947A1 · Gadagkar et al. · 2010 [cited by applicant]
US 20110093046A1 · Ellingson et al. · 2011 [cited by applicant]
US 20110106204A1 · Yoon et al. · 2011 [cited by applicant]
US 20110152672A1 · Doerr et al. · 2011 [cited by applicant]
US 20110160565A1 · Stubbs et al. · 2011 [cited by applicant]
US 20110160602A1 · Stubbs et al. · 2011 [cited by applicant]
US 20110160791A1 · Ellingson et al. · 2011 [cited by applicant]
US 20110160806A1 · Lyden · 2011 [cited by examiner]
US 20110187360A1 · Maile et al. · 2011 [cited by applicant]
US 20110196450A1 · McClure et al. · 2011 [cited by applicant]
US 20120221068A1 · Ellingson · 2012 [cited by applicant]
US 20120245452A1 · Doerr et al. · 2012 [cited by applicant]
US 20120253425A1 · Yoon et al. · 2012 [cited by applicant]
US 20120277817A1 · Ellingson et al. · 2012 [cited by applicant]
US 20130268012A1 · Sison · 2013 [cited by applicant]
US 20130289384A1 · Jenison et al. · 2013 [cited by applicant]
US 20130289638A1 · Newman · 2013 [cited by examiner]
US 20140100624A1 · Ellingson · 2014 [cited by applicant]
US 20160015986A1 · Seeberger · 2016 [cited by applicant]
US 20160151623A1 · Doerr · 2016 [cited by applicant]
US 20160151624A1 · Doerr · 2016 [cited by applicant]
US 20180140856A1 · Lindevig et al. · 2018 [cited by applicant]
US 20190201701A1 · Balczewski et al. · 2019 [cited by applicant]
US 20200230423A1 · Chen et al. · 2020 [cited by applicant]
US 20230027466A1 · Ellingson et al. · 2023 [cited by applicant]
US 20230061204A1 · Edmonson et al. · 2023 [cited by applicant]
US 20230166114A1 · Doerr et al. · 2023 [cited by applicant]
US 20230364430A1 · Yoon et al. · 2023 [cited by applicant]
US 20240207620A1 · Yoon et al. · 2024 [cited by applicant]
CN 106110503 · 2016 [cited by applicant]
EP 1935450A1 · 2008 [cited by applicant]
WO 2010126935A2 · 2010 [cited by applicant]
PCT/IB2022/061272 International Search Report and Written Opinion, Feb. 17, 2023. [cited by applicant]
Kloostermann, Dr. E. Martin, MRI Remote Control Study (ROCON) Remote Management of Cardiac Devices Undergoing MRI, 7 pgs. [cited by applicant]
Kloostermann, Dr. E. Martin, MRI Remote Control Study (ROCON). Remote Management of Cardiac Devices Undergoing MRI, 30 pgs. [cited by applicant]
Kloostermann, Dr. E. Martin,, “Novel MRI Safe Mode Selection Algorithm Standardized Real-Time Solutions for a Varialbe Time-Dependent Problem”, J. Clin Exp. Cardiology, Dec. 11-12, 2017, 22nd World Cardiology Conference. [cited by applicant]